Thomas James Doyle, SVP, Finance & Accounting at Kura Oncology, Inc. (KURA), sold 4,949 shares at $7.87 ($39K) on 2025-01-28, disclosed to the SEC on 2025-01-28.
Open-market sale of $39k KURA by SVP, Finance & Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.87 | 699 | $6K | 14.1% |
| 2 | $7.87 | 887 | $7K | 17.9% |
| 3 | $7.87 | 1,122 | $9K | 22.7% |
| 4 | $7.87 | 2,241 | $18K | 45.3% |
| Total | $7.87 avg | 4,949 | $39K | 100% |
| Filing → |
| KURA | SELL | 2025-11-14 | $101K | — | Filing → |
| KURA | SELL | 2025-09-29 | $41K | — | Filing → |
| KURA | SELL | 2024-01-31 | $41K | — | Filing → |